Bertrand Dautzenberg

5.5k total citations · 1 hit paper
135 papers, 3.6k citations indexed

About

Bertrand Dautzenberg is a scholar working on Epidemiology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bertrand Dautzenberg has authored 135 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 37 papers in Physiology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bertrand Dautzenberg's work include Smoking Behavior and Cessation (36 papers), Tuberculosis Research and Epidemiology (28 papers) and Mycobacterium research and diagnosis (26 papers). Bertrand Dautzenberg is often cited by papers focused on Smoking Behavior and Cessation (36 papers), Tuberculosis Research and Epidemiology (28 papers) and Mycobacterium research and diagnosis (26 papers). Bertrand Dautzenberg collaborates with scholars based in France, United Kingdom and Italy. Bertrand Dautzenberg's co-authors include Alain Mercat, R. Arriagada, B Lebeau, P. Diot, Claude Chastang, J Grosset, M.H. Becquemin, Brigitte Fauroux, Edmond Chailleux and J M Polu and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Bertrand Dautzenberg

129 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials

1998 580 citations Bertrand Dautzenberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bertrand Dautzenberg France	26	1.6k	945	796	683	411	135	3.6k
Digambar Behera India	31	1.9k 1.2×	1.2k 1.2×	611 0.8×	1.7k 2.6×	454 1.1×	145	4.3k
Ji Ye Jung South Korea	34	1.6k 1.1×	1.1k 1.1×	849 1.1×	651 1.0×	420 1.0×	243	4.2k
Harland Austin United States	42	875 0.6×	847 0.9×	488 0.6×	390 0.6×	682 1.7×	110	5.6k
Randeep Guleria India	27	1.4k 0.9×	553 0.6×	730 0.9×	892 1.3×	191 0.5×	207	3.2k
Gláucia Zanetti Brazil	38	1.7k 1.1×	1.3k 1.4×	393 0.5×	918 1.3×	276 0.7×	319	5.0k
Jung Hyun Chang South Korea	28	1.1k 0.7×	377 0.4×	572 0.7×	299 0.4×	308 0.7×	133	2.4k
Moira Chan‐Yeung Canada	33	1.2k 0.8×	516 0.5×	864 1.1×	1.0k 1.5×	184 0.4×	80	3.5k
Zhaohui Tong China	28	1.3k 0.9×	632 0.7×	216 0.3×	955 1.4×	320 0.8×	191	3.5k
Yeon‐Mok Oh South Korea	40	3.8k 2.4×	859 0.9×	1.4k 1.7×	528 0.8×	183 0.4×	358	5.9k
Michael S. Stulbarg United States	30	1.5k 0.9×	755 0.8×	426 0.5×	292 0.4×	131 0.3×	48	2.8k

Countries citing papers authored by Bertrand Dautzenberg

Since Specialization

Citations

This map shows the geographic impact of Bertrand Dautzenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Dautzenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Dautzenberg more than expected).

Fields of papers citing papers by Bertrand Dautzenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Dautzenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Dautzenberg. The network helps show where Bertrand Dautzenberg may publish in the future.

Co-authorship network of co-authors of Bertrand Dautzenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Dautzenberg. A scholar is included among the top collaborators of Bertrand Dautzenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Dautzenberg. Bertrand Dautzenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goupil, François, et al.. (2021). Use of a Smartphone Self-assessment App for a Tobacco-Induced Disease (COPD, Cardiovascular Diseases, Cancer) Screening Strategy and to Encourage Smoking Cessation: Observational Study. JMIR Public Health and Surveillance. 8(2). e19877–e19877. 3 indexed citations

Dautzenberg, Bertrand, et al.. (2016). Satisfactory throat-hit is needed to switch from tobacco to e-cigarettes: a lesson from an e-liquid blind test. Tobacco Prevention & Cessation. 2(April). 8 indexed citations

Dautzenberg, Bertrand, M. Adler, G. Peiffer, et al.. (2014). Adaptations de la prise en charge de l’arrêt du tabac avec l’arrivée de la cigarette électronique ? Avis d’experts de l’Office français de prévention du tabagisme (OFT) 2014. Revue des Maladies Respiratoires. 31(7). 641–645. 5 indexed citations

Dautzenberg, Bertrand, et al.. (2013). E-Cigarette: A New Tobacco Product for Schoolchildren in Paris. 3(1). 21–24. 44 indexed citations

Ngahane, Bertrand Hugo Mbatchou, et al.. (2012). Prévalence du tabagisme chez le personnel de l'Hôpital Général de Douala, Cameroun. SHILAP Revista de lepidopterología. 1 indexed citations

Aveyard, Paul & Bertrand Dautzenberg. (2010). Temporary abstinence from smoking prior to surgery reduces harm to smokers. International Journal of Clinical Practice. 64(3). 285–288. 1 indexed citations

Becquemin, M.H., et al.. (2010). Rétention dans les voies aériennes des particules nanométriques de l’aérosol de la fumée de cigarette au cours du tabagisme passif. Revue des Maladies Respiratoires. 27(5). 441–448. 5 indexed citations

Hejblum, Gilles, Kokuvi Atsou, Bertrand Dautzenberg, & C. Chouaïd. (2008). Cost-Benefit Analysis of a Simulated Institution-Based Preoperative Smoking Cessation Intervention in Patients Undergoing Total Hip and Knee Arthroplasties in France. CHEST Journal. 135(2). 477–483. 25 indexed citations

Becquemin, M.H., et al.. (2007). Tailles particulaires de la fumée produite par six différents types de cigarettes. Revue des Maladies Respiratoires. 24(7). 845–852. 25 indexed citations

10.

Chouaïd, C., et al.. (2005). La lutte antituberculeuse en France : évaluation des pratiques par un groupe de travail de la SPLF auprès des services de lutte antituberculeuse. Revue des Maladies Respiratoires. 22(1). 45–54. 6 indexed citations

11.

Bøe, J, John Dennis, B. Ronan O’Driscoll, et al.. (2001). European Respiratory Society Guidelines on the use of nebulizers. European Respiratory Journal. 18(1). 228–242. 203 indexed citations

12.

Bonnaud, F, et al.. (1999). [The air that we breathe].. PubMed. 16 Suppl 3. S201–2. 1 indexed citations

13.

Jouveshomme, Stéphane, Bertrand Dautzenberg, H Bakdach, & Jean‐Philippe Derenne. (1998). Preliminary Results of Collapse Therapy with Plombage for Pulmonary Disease Caused by Multidrug-resistant Mycobacteria. American Journal of Respiratory and Critical Care Medicine. 157(5). 1609–1615. 25 indexed citations

14.

Dautzenberg, Bertrand. (1997). The use of rifabutin in Europe for the treatment of mycobacterial infection in AIDS patients. Infection. 25(1). 63–66. 5 indexed citations

15.

Dautzenberg, Bertrand. (1996). Rifabutin in the Treatment of Mycobacterium avium Complex Infection: Experience in Europe. Clinical Infectious Diseases. 22(Supplement_1). S33–S36. 4 indexed citations

16.

Dautzenberg, Bertrand, et al.. (1996). Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients. Antimicrobial Agents and Chemotherapy. 40(7). 1722–1725. 11 indexed citations

17.

Dautzenberg, Bertrand, et al.. (1995). Clarithromycin in the Treatment of Mycobacterium avium Lung Infections in Patients Without AIDS. CHEST Journal. 107(4). 1035–1040. 116 indexed citations

18.

Dautzenberg, Bertrand, et al.. (1989). LA RIFABUTINE DANS LE TRAITEMENT DES INFECTIONS A MYCOBACTERIES RESISTANTES A LA RIFAMPICINE. RESULTATS PRELIMINAIRES. Revue des Maladies Respiratoires. 6(4). 335–342. 3 indexed citations

19.

Paget, Derek, et al.. (1989). Peut-on limiter la prise de poids chez les fumeurs lors du sevrage tabagique en utilisant la gomme à la nicotine?. Revue de Pneumologie Clinique. 45(6). 1 indexed citations

20.

Nguyen, Jacqueline, Vincent Jarlier, Bertrand Dautzenberg, et al.. (1986). [Evolution of the resistance of Streptococcus pneumoniae to erythromycin at the Pitié-Salpêtrière Hospital (1980-1984)].. PubMed. 3(5). 263–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact